Will resume COVID-19 vaccine trials after DCGI nod: Serum Institute

Shouldn’t jump to conclusions until trails are complete, says CEO Adar Poonawalla

Will resume COVID-19 vaccine trials after DCGI nod: Serum Institute

File photo

New Delhi, September 12

Serum Institute of India said on Saturday that it would resume clinical trials of AstraZeneca’s COVID-19 vaccine candidate after getting the permission from the Drugs Controller General of India (DCGI) ---a development that comes after the company said trials had resumed after a pause.

Pharma giant AstraZeneca on Saturday said that clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that the trials were safe.

“Once DCGI will give us the permission to restart the trials in India, we will resume the trials,” Serum Institute of India (SII) said in a statement.

In a tweet, SII CEO Adar Poonawalla said: “As I’d mentioned earlier, we should not jump to conclusions until the trials are fully concluded. The recent chain of events is a clear example why we should not bias the process and should respect the process till the end. Good news, @UniofOxford”.  The human trials resumed days after a pause had been announced in the trials after an adverse reaction in one of the participants.

Following the suspension, the DCGI directed Serum Institute of India to suspend till further orders new recruitment in phase 2 and 3 clinical trials of the vaccine candidate.

AstraZeneca and the University of Oxford, as the trial sponsor, on Saturday said that they cannot disclose further medical information but confirmed that independent investigations concluded that the trials were safe to restart. PTI

 

Top Stories

India, US ink military pact, set stage for expanding collaboration

India, US ink military pact, set stage for expanding collaboration

Trade, people-to-people ties remain in limbo; more tie-ups i...

Govt paves way for all Indians to buy land in Jammu and Kashmir

Govt paves way for all Indians to buy land in Jammu and Kashmir

Union Home Ministry repeals 12 laws enacted by the erstwhile...

India declares 18 Pakistan-based individuals as designated terrorists under UAPA

India declares 18 Pakistan-based individuals as designated terrorists under UAPA

The list issued by the MHA has names of Chhota Shakeel, Bhat...

Facebook India’s Ankhi Das steps down to pursue 'public service'

Facebook India’s Ankhi Das steps down to pursue 'public service'

Comes two months after allegations that she stopped company ...

Cities

View All